
AI-Based Drug Development Company Xbiome Completed B-Round Financing Worth Nearly US$100 Million
Xbiome Biotech Co., Ltd., an AI-based microbiome drug development company in Shenzhen, China, announced the completion of a B-round of financing totaling nearly $100 million.